Edwards Lifesciences Corporation (EW)

NYSE: EW · Real-Time Price · USD

86.29

+0.56 (0.65%)

At close: Sep 25, 2026, 4:00 PM EDT

85.50

-0.79 (-0.92%)

After-hours: Sep 25, 2026, 7:30 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Transcatheter Aortic Valve Replacement Revenue	4.77B	4.49B	4.11B
Transcatheter Mitral and Tricuspid Therapies Revenue	674.60M	550.60M	352.10M
Surgical Structural Heart Revenue	1.07B	1.03B	981.30M
Revenue (Total)	6.51B	6.07B	5.44B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.